Buy AM-2201 Online,AM-2201 is a research chemical of the Cannabinoid family. At the Cannabinoid receptor, AM-2201 is a non selective full agonist. Discovered by Alexandros Makriyannis, AM-2201 is part of the AM Series of cannabinoid receptor ligand. AM-2201 is active at extremely low quantities, as low as 0.02g.
What is AM-2201 used for?
AM-2201 can be used to further research the in vitro (outside living organism) efficacy it has upon the cannabinoid receptors. Due to its non-selectivity, AM-2201 is useful for broad ligand binding assays into the affinity (potency) and duration of action upon receptors. Affinities are: Ki of 1.0nM at CB1 and 2.6nM at CB2. AM-2201 can be combusted using heat to produce a vapour. This vapour is useful as it contains AM-2201 with a high surface area, enabling efficient contact when applied to a membrane containing cannabinoid receptors CB1 and CB2.
AM-2201may be used by chemical catalogue companies to analyse it using NMR, GC/MS,FTIR or HPLC. This analysis can be used by toxicology and forensic scientists as a reference for comparison. Chemists may also use AM-2201 as primary reagent for their specific studies
Buy AM-2201 Online
AM-2201 has a reputation in research circles as being the most potent chemical in the cannabinoid class. A full agonist for the associated receptors, it is active in doses as small as 500 micrograms, and therefore should be handled with extreme caution to avoid involuntary inhalation.Buy AM-2201 Online
The fact it has such a broad receptor binding profile has made AM-2201 an extremely popular choice among researchers. It is sold by BAC strictly for the purposes of in vitro application only, and is not suitable for human ingestion. Talk with us here or proceed to check out
AM-2201 is a full agonist for cannabinoid receptors. Affinities are: with a Ki of 1.0 nM at CB1 and 2.6 nM at CB2.The 4-methyl functional analog MAM-2201 probably has similar affinities.[original research?] AM-2201 has an EC50 of 38 nM for human CB1 receptors, and 58 nM for human CB2 receptors.AM-2201 produces bradycardia and hypothermia in rats at doses of 0.3–3 mg/kg, comparable to the potency of JWH-018 in rats, suggesting potent cannabinoid-like activity.